162 related articles for article (PubMed ID: 17449237)
21. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
[TBL] [Abstract][Full Text] [Related]
22. The 13q and 11q B-cell chronic lymphocytic leukaemia-associated regions derive from a common ancestral region in the zebrafish.
Auer RL; Riaz S; Cotter FE
Br J Haematol; 2007 Jun; 137(5):443-53. PubMed ID: 17488487
[TBL] [Abstract][Full Text] [Related]
23. Genetic alteration associated with chronic lymphocytic leukemia.
Cotter FE; Auer RL
Cytogenet Genome Res; 2007; 118(2-4):310-9. PubMed ID: 18000385
[TBL] [Abstract][Full Text] [Related]
24. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.
Herold T; Jurinovic V; Mulaw M; Seiler T; Dufour A; Schneider S; Kakadia PM; Feuring-Buske M; Braess J; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Bohlander SK
Genes Chromosomes Cancer; 2011 Jul; 50(7):546-58. PubMed ID: 21500311
[TBL] [Abstract][Full Text] [Related]
25. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
26. Rb1 gene expression in B-cell lymphocytic leukaemia cases with deletion in the 13q14 region.
Antosz H; Kitlińska J; Kwiatkowska-Drabik B; Koczkodaj D; Wach M; Antosz M; Rudzki S; Wojcierowski J
Cytobios; 1997; 92(369):111-21. PubMed ID: 9693880
[TBL] [Abstract][Full Text] [Related]
27. 11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.
Dickinson JD; Gilmore J; Iqbal J; Sanger W; Lynch JC; Chan J; Bierman PJ; Joshi SS
Leuk Lymphoma; 2006 Feb; 47(2):231-44. PubMed ID: 16321852
[TBL] [Abstract][Full Text] [Related]
28. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia.
Mabuchi H; Fujii H; Calin G; Alder H; Negrini M; Rassenti L; Kipps TJ; Bullrich F; Croce CM
Cancer Res; 2001 Apr; 61(7):2870-7. PubMed ID: 11306461
[TBL] [Abstract][Full Text] [Related]
29. Gene dosage effects in chronic lymphocytic leukemia.
Sellmann L; Scholtysik R; Kreuz M; Cyrull S; Tiacci E; Stanelle J; Carpinteiro A; Nückel H; Boes T; Gesk S; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
Cancer Genet Cytogenet; 2010 Dec; 203(2):149-60. PubMed ID: 21156227
[TBL] [Abstract][Full Text] [Related]
30. A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.
Pekova S; Mazal O; Cmejla R; Hardekopf DW; Plachy R; Zejskova L; Haugvicova R; Jancuskova T; Karas M; Koza V; Smolej L; Bezdickova L; Kozak T
Leuk Res; 2011 Jul; 35(7):889-98. PubMed ID: 21232794
[TBL] [Abstract][Full Text] [Related]
31. Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
Rees-Unwin KS; Faragher R; Unwin RD; Adams J; Brown PJ; Buckle AM; Pettitt A; Hutchinson CV; Johnson SM; Pulford K; Banham AH; Whetton AD; Lucas G; Mason DY; Burthem J
Br J Haematol; 2010 Feb; 148(4):534-43. PubMed ID: 19961478
[TBL] [Abstract][Full Text] [Related]
32. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia.
Eisele L; Prinz R; Klein-Hitpass L; Nückel H; Lowinski K; Thomale J; Moeller LC; Dührsen U; Dürig J
Eur J Haematol; 2009 Oct; 83(4):320-7. PubMed ID: 19500131
[TBL] [Abstract][Full Text] [Related]
33. Mutagenicity of non-homologous end joining DNA repair in a resistant subset of human chronic lymphocytic leukaemia B cells.
Deriano L; Merle-Béral H; Guipaud O; Sabatier L; Delic J
Br J Haematol; 2006 Jun; 133(5):520-5. PubMed ID: 16681639
[TBL] [Abstract][Full Text] [Related]
34. A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia.
Gardiner A; Parker H; Glide S; Mould S; Robinson H; Tracy I; Stankovic T; Oscier D; Strefford J
Leuk Res; 2012 Mar; 36(3):307-10. PubMed ID: 21955805
[TBL] [Abstract][Full Text] [Related]
35. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
[TBL] [Abstract][Full Text] [Related]
36. A unique lethal blastoid transformation of B-cell chronic lymphocytic leukemia carrying ATM/11q deletion and trisomy 12.
Lu Y; Huang Q
Leuk Res; 2009 Aug; 33(8):e124-6. PubMed ID: 19269030
[No Abstract] [Full Text] [Related]
37. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage.
Britt-Compton B; Lin TT; Ahmed G; Weston V; Jones RE; Fegan C; Oscier DG; Stankovic T; Pepper C; Baird DM
Leukemia; 2012 Apr; 26(4):826-30. PubMed ID: 21986843
[No Abstract] [Full Text] [Related]
38. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.
Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G
Clin Cancer Res; 2009 Feb; 15(3):995-1004. PubMed ID: 19188171
[TBL] [Abstract][Full Text] [Related]
39. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
40. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
Calin GA; di Iasio MG; Caprini E; Vorechovsky I; Natali PG; Sozzi G; Croce CM; Barbanti-Brodano G; Russo G; Negrini M
Oncogene; 2000 Feb; 19(9):1191-5. PubMed ID: 10713707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
